APA

Behr T. M., Sharkey R. M., Juweid M. E., Dunn R. M., Vagg R. C., Ying Z., Zhang C. H., Swayne L. C., Vardi Y., Siegel J. A. & Goldenberg D. M. (19970714). Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Chicago

Behr T M, Sharkey R M, Juweid M E, Dunn R M, Vagg R C, Ying Z, Zhang C H, Swayne L C, Vardi Y, Siegel J A and Goldenberg D M. 19970714. Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Harvard

Behr T. M., Sharkey R. M., Juweid M. E., Dunn R. M., Vagg R. C., Ying Z., Zhang C. H., Swayne L. C., Vardi Y., Siegel J. A. and Goldenberg D. M. (19970714). Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

MLA

Behr T M, Sharkey R M, Juweid M E, Dunn R M, Vagg R C, Ying Z, Zhang C H, Swayne L C, Vardi Y, Siegel J A and Goldenberg D M. Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 19970714.